Home>Topics>Stocks>Teva Pharmaceutical Industries

Teva Pharmaceutical Industries TEVA

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. BRIEF-Active Biotech says patient enrollment in laquinimod trial completed

      Headlines

      Thu, 25 Jun 2015

      * Active Biotech: Teva and Active Biotech announce completion of patient enrollment in laquinimod phase III Concerto trial

    2. Teva raises stake in Mylan as three-way takeover battle heats up

      Headlines

      Fri, 19 Jun 2015

      June 19 (Reuters) - Israel's Teva Pharmaceutical Industries Ltd has raised its stake in Mylan N.V. to the 4.61 percent needed for it to legally challenge Mylan's rejection of Teva 's hostile takeover...

    3. UPDATE 2-U.S. appeals court again invalidates Teva's MS drug patent

      Headlines

      Thu, 18 Jun 2015

      NEW YORK, June 18 (Reuters) - A U.S. appeals court on Thursday once again invalidated a patent held by Teva Pharmaceutical Industries Ltd on its top-selling multiple sclerosis drug Copaxone, clearing the way for the launch of a cheaper, generic version.

    4. U.S. appeals court again invalidates Teva MS drug patent

      Headlines

      Thu, 18 Jun 2015

      NEW YORK, June 18 (Reuters) - A U.S. appeals court on Thursday once again invalidated a patent held by Teva Pharmaceutical Industries Ltd on its top-selling multiple sclerosis drug Copaxone, clearing...

    5. REFILE-UPDATE 1-Abbott to vote for Mylan's acquisition of Perrigo

      Headlines

      Tue, 16 Jun 2015

      June 16 (Reuters) - Mylan NV's largest stakeholder, Abbott Laboratories, said it would back Mylan's proposed acquisition of Perrigo Co Plc, potentially helping Mylan fend off interest from Teva ...

    6. Teva bosses issue riposte to Mylan, praise takeover plan

      Headlines

      Mon, 8 Jun 2015

      AMSTERDAM (Reuters) - Executives at Israeli drugmaker Teva sent an open letter to takeover target Mylan on Monday, saying they remain committed to a deal and reiterated that Teva 's $40 billion takeover proposal would benefit shareholders of both firms.

    7. UPDATE 2- Teva bosses issue riposte to Mylan, praise takeover plan

      Headlines

      Mon, 8 Jun 2015

      AMSTERDAM, June 8 (Reuters) - Executives at Israeli drugmaker Teva sent an open letter to takeover target Mylan on Monday, saying they remain committed to a deal and reiterated that Teva 's $40 billion takeover proposal would benefit shareholders of both firms.

    8. Teva bosses say remain committed to Mylan takeover

      Headlines

      Mon, 8 Jun 2015

      AMSTERDAM, June 8 (Reuters) - Top executives at Israeli drugmaker Teva sent an open letter to takeover target Mylan on Monday, saying they remained committed to striking a deal and reasserting that...

    9. Teva raises its stake in acquisition target Mylan

      Headlines

      Fri, 5 Jun 2015

      (Reuters) - Teva Pharmaceutical Industries Ltd has increased its stake in Mylan NV to nearly 2.2 percent as it presses on with an unsolicited bid for its generic drug-making rival, a regulatory filing showed on Friday.

    10. Teva raises its stake in acquisition target Mylan

      Headlines

      Fri, 5 Jun 2015

      June 5 (Reuters) - Teva Pharmaceutical Industries Ltd has increased its stake in Mylan NV to nearly 2.2 percent as it presses on with an unsolicited bid for its generic drug-making rival, a regulatory filing showed on Friday.

    « Prev12345Next »
    Content Partners